Share Email Print
cover

Proceedings Paper

Topical delivery of a preformed photosensitizer for photodynamic therapy of cutaneous lesions
Author(s): Nancy L. Oleinick; Malcolm E. Kenney; Minh Lam; Thomas McCormick; Kevin D. Cooper; Elma D. Baron
Format Member Price Non-Member Price
PDF $17.00 $21.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

Photosensitizers for photodynamic therapy (PDT) are most commonly delivered to patients or experimental animals via intravenous injection. After initial distribution throughout the body, there can be some preferential accumulation within tumors or other abnormal tissue in comparison to the surrounding normal tissue. In contrast, the photosensitizer precursor, 5-aminolevulinic acid (ALA) or one of its esters, is routinely administered topically, and more specifically, to target skin lesions. Following metabolic conversion to protoporphyrin IX, the target area is photoilluminated, limiting peripheral damage and targeting the effective agent to the desired region. However, not all skin lesions are responsive to ALA-PDT. Topical administration of fully formed photosensitizers is less common but is receiving increased attention, and some notable advances with selected approved and experimental photosensitizers have been published. Our team has examined topical administration of the phthalocyanine photosensitizer Pc 4 to mammalian (human, mouse, pig) skin. Pc 4 in a desired formulation and concentration was applied to the skin surface at a rate of 5-10 μL/cm2 and kept under occlusion. After various times, skin biopsies were examined by confocal microscopy, and fluorescence within regions of interest was quantified. Early after application, images show the majority of the Pc 4 fluorescence within the stratum corneum and upper epidermis. As a function of time and concentration, penetration of Pc 4 across the stratum corneum and into the epidermis and dermis was observed. The data indicate that Pc 4 can be delivered to skin for photodynamic activation and treatment of skin pathologies.

Paper Details

Date Published: 9 March 2012
PDF: 8 pages
Proc. SPIE 8210, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXI, 821003 (9 March 2012); doi: 10.1117/12.909029
Show Author Affiliations
Nancy L. Oleinick, Case Comprehensive Cancer Ctr. (United States)
Case Western Reserve Univ. (United States)
Univ. Hospitals Case Medical Ctr. (United States)
Malcolm E. Kenney, Case Comprehensive Cancer Ctr. (United States)
Minh Lam, Case Comprehensive Cancer Ctr. (United States)
Case Western Reserve Univ. (United States)
Univ. Hospitals Case Medical Ctr. (United States)
Thomas McCormick, Case Comprehensive Cancer Ctr. (United States)
Case Western Reserve Univ. (United States)
Univ. Hospitals Case Medical Ctr. (United States)
Kevin D. Cooper, Case Comprehensive Cancer Ctr. (United States)
Case Western Reserve Univ. (United States)
Univ. Hospitals Case Medical Ctr. (United States)
Elma D. Baron, Case Comprehensive Cancer Ctr. (United States)
Case Western Reserve Univ. (United States)
Univ. Hospitals Case Medical Ctr. (United States)


Published in SPIE Proceedings Vol. 8210:
Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXI
David H. Kessel; Tayyaba Hasan, Editor(s)

© SPIE. Terms of Use
Back to Top